AAS
@atheroaussie
Followers
486
Following
458
Media
281
Statuses
641
The Australian Atherosclerosis Society (AAS) promotes, at a national level, the advancement of science, research and teaching in the field of atherosclerosis
Australia and New Zealand
Joined January 2012
Join us to her about some cutting-edge research at the joint virtual seminar, delivered by Dr Jonathan Noonan from the Baker Heart and Diabetes Institute
0
0
0
Abstracts are due soon! Don't miss out on the opportunity to present your work at the AAS ASM 2025. Submit using the link: https://t.co/eIWNp4H7Ay
0
1
4
Abstract submission is open for our annual scientific meeting! Submit via: https://t.co/sTWiLKzT5Z
0
1
2
The June AAS, AVBS, ANZMS joint virtual seminar will be held today- hope to see you there!
0
0
2
We are delighted to have @ChrisBursill representing Australia and the Asia Pacific on the IAS board!
The Council of Constituents Societies met on December 6 to vote on a new board of directors for the 2025-2027 term. The International Atherosclerosis Society is proud to announce its new board, effective January 1: π£πΏπ²ππΆπ±π²π»π: Dirk Blom, MBChB, MMed - South Africa
1
1
11
SAHMRI PhD student, Demeke Geremew had a very engaged audience at the poster session! #ISA2024
0
1
7
Great representation by the AAS members at #ISA2024
Some excellent talks from @atheroaussie executives and members at the #ISA2024 . This marked last day group photo @atherosociety
0
0
5
In her second talk for the morning, @ChrisBursill is delivering a sponsored lunchtime lecture on Inflammation in Atherosclerosis #ISA2024
1
3
12
Former AAS President and long time member, @ChrisBursill delivered an excellent talk about the protective role of NRF2 activation in reducing plaque burden and instability #ISA2024
1
2
10
Great to see more AAS member contribution at #ISA2024
@atheroaussie executive @kristenbubb presenting her research on plaque stability effects of Omega 3 at the ##ISA2024
@atherosociety
0
1
3
Our long standing AAS board member, Prof Gerald Watts, presented late-breaking data showing results of the PALISADE trial which identifies a new apoC3 inhibitor-based treatment to lower triglycerides and reduce pancreatitis in patients with FCS. Published in NEJM #ISA2024
0
1
5
The AAS is equally proud of one of our Rising Stars, presenting at #ISA2024
Proud supervisor moment, @Misbah_Aziz1 presenting our epigenetics EndMT in atherosclerisis story at the #ISA2024 @atherosociety @atheroaussie
3
1
9
Exciting to see this international symposium on athero starting today! #ISA2024
For the first time in-person since 2018, join IAS for #ISA2024 in Muskat, Oman. Register today: https://t.co/lIRjGudzxc
0
3
8
See link below to submit your abstract for #EASCongress2025. There are three travel bursaries available for AAS members to attend valued at β¬400 each!
β³ Donβt miss the chance to present your research at #EASCongress2025! This is your moment to share your latest findings & make an impact on the field of #atherosclerosis. Submit your abstract here β‘οΈ https://t.co/OgrcEX9EHh
#AtherosclerosisResearch #HeartHealthExperts
0
1
4
Closing out the FH Summit is the interactive workshop focusing on the development of risk-reduction pathway for children led by @MitchellSarkies with insights from Shubha Srinivasan, Natalie Taylor & Andrew Martin.
0
0
2
We now move onto our Workshop session of the FH Summit. Natalie Taylor shares her thoughts on early implementation such as newborn screening can advance FH identification.
0
0
1